Lamenting the lack of a diagnostic biomarker for FM, U.S. researchers turned to measuring the expression of the genes in FM patients blood. Their findings suggested FM was a neuro-immune disease with a twist.
I found the focus on gene expression and mast-cell activity particularly interesting, especially given the ongoing challenge of identifying reliable biomarkers for fibromyalgia. I’d be interested to know whether later research has confirmed these inflammatory and neuro-immune patterns and whether they could eventually help distinguish fibromyalgia from other conditions with overlapping slope symptoms.
I’m curious, how do you think future research might further elucidate the connection between genetic markers and treatment options fnaf? Also, do you see any potential for these findings to influence lifestyle recommendations?
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.
I found the focus on gene expression and mast-cell activity particularly interesting, especially given the ongoing challenge of identifying reliable biomarkers for fibromyalgia. I’d be interested to know whether later research has confirmed these inflammatory and neuro-immune patterns and whether they could eventually help distinguish fibromyalgia from other conditions with overlapping slope symptoms.
I’m curious, how do you think future research might further elucidate the connection between genetic markers and treatment options fnaf? Also, do you see any potential for these findings to influence lifestyle recommendations?